Antihypertensive drugs and sleep;Antihypertensive medikation und schlaf

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 46, 1998, Pages 1389-1394

  Grote, L ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIURETIC AGENT; GUANABENZ; METHYLDOPA; PRAZOSIN; RESERPINE;

BRUXISM; CLINICAL OBSERVATION; DRUG CROSS REACTIVITY; HUMAN; HYPERTENSION; MYOCLONUS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SLEEP PATTERN;

EID: 0032514923     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024193     Document Type: Review

References (48)

1. Aldrich, M. S., A. E. Rogers: Exacerbation of human cataplexy by prazosin. Sleep. 12 (1989), 254-256.
2. Amir, M., N. Cristal, O. D. Bar, A. Loidl: Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience. Blood Press. Suppl. 1 (1994), 40-42.
3. Betts, T. A., C. Alford: Beta-blockers and sleep: a controlled trial. Europ. J. Clin. Pharmacol., 28 Suppl. (1985), 65-68.
4. Bolland, G., B. Bauer, H. J. Seyfarth: Reaction performance, motor coordination performance and findings in hypertensive patients under diisopropylamine and reserpine therapy. Z. Ges. Inn. Med. 34 (1979), 701-703.
5. Cameron, O. G., G. C. Curtis, T. Zelnik, D. McCann, T. Roth, K. Guire, S. M. Huber: Circadian fluctuation of plasma epinephrine in su-pine humans. Psychoneuroendocrinology 12 (1987), 41-51.
6. Croog, S. H., S. Levine, M. A.Testa, B. Brown, C.J. Bulpitt, C. D. Jenkins, G. L Klerman, G. H. Williams: The effects of antihypertensive therapy on the quality of life. New Engl. J. Med. 314 (1986), 1657-1664.
7. Danchin, N., P. Genton, P. Atlas, J. Anconina, J. Leclere, F. Cherrier: Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int. J. Clin. Pharmacol. Ther. 33 (1995), 52-55.
8. Dimsdale, J. E.: Reflections on the Impact of Antihypertensive Medications on Mood, Sedation, and Neuropsychologic Functioning. Arch. Intern. Med. 152 (1992), 35-39.
9. Dodt, C., U. Breckling, I. Derad, H. L Fehm, J. Born: Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 30 (1997), 71-76.
10. Gascon, M. P., P. Dayer: In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. Europ. J. Clin. Pharmacol. 41 (1991), 573-578.
11. Grote, L.J. Heitmann, T. Penzel, W. Cassel, T. Ploch, J. H. Peter, P. von Wichert: Daytime versus nighttime blood pressure recording in hypertensive OSAS patients before and during drug administration (Cilazapril/Placebo). Blood Pressure 6 (1997), s235-s241.
12. Issa, F. G.: Effect of clonidine in obstructive sleep apnea. Amer. Rev. Respir. Dis. 145 (1992), 435-439.
13. Jarrott, B., S. Lewis, E. L. Conway, R. Summers, W. J. Louis: The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat. Clin. Exp. Hypertens. A., 6 (1984), 387-400.
14. Jus, A., A. Villeneuve, J. Gautier, P. Pires, R. Lachance, Villeneuve: Influence of reserpine on all-night sleep pattern in nonlobotomized and lobotomized chronic schizophrenic patients. Biol. Psychiatry 10 (1975), 17-25.
15. Kantola, I., E. Rauhala, M. Erkinjuntii, L. Mansury: Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J. Cardiovasc. Pharmacol., 18 Suppl. 3 (1991), S41-S45.
16. Kuriyama, S.: Bisoprolol-induced nightmares (letter). J. Hum. Hypertens. 8 (1994), 730.
17. Lacourciere, Y.: Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril. Amer. J. Med. 84 (1988), 47-52.
18. Lahive, K. C., J. W. Weiss, S. E. Weinberger: Alpha-methyldopa selectively reduces alae nasi activity. Clin. Sci. 74 (1988), 547-551.
19. Mann, K., T. Klingler, S. Noe, J. Roschke, S. Muller, O. Benkert: Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch. Sex. Behav. 25 (1996), 1-16.
20. Mastrangelo, D., K. de-Saint-Hilaire, J. M. Gaillard: Effects of clonidine and alpha-methyl-p-tyrosine on the carbachol stimulation of paradoxical sleep. Pharmacol. Biochem. Behav. 48 (1994), 93-100.
21. Mayer, J., U. Weichler, B. Herres-Mayer, H. Schneider, U. Marx, J. H. Peter: Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J. Cardiovasc. Pharmacol. 16 (1990), 952-961.
22. McCormick, D. A., H. C. Pape, A. Williamson: Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88 (1991), 293-305.
23. Mignot, E., C. Guilleminault, S. Bowersox, B. Frusthofer, S. Nishino, J. Maddaluno, R. Ciaranello, W. C. Dement: Central alpha-1-adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep. Brain Research 490 (1989), 186-191.
24. Mirmiran, M.: The importance of fetal/neonatal REM sleep. Europ. J. Obstet. Gynecol. Reprod. Biol. 21 (1986), 283-291.
25. Monti, J. M: Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci. 41 (1987), 1979-1988.
26. Nicholson, A. N., C. M. Bradley, P. A. Pascoe: Medications: Effect on sleep and wakefulness. In Kryger, M. H., T. Roth, W. C. Dement (eds.): Principles and Practice of Sleep Medicine (W. B. Saunders: London 1994), 364-372.
27. Nicholson, A. N., P. A. Pascoe: 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man. Neuropharmacology 25 (1986), 1079-1083.
28. Nicholson, A. N., P. A. Pascoe: Dopaminergic transmission and the sleep-wakefulness continuum in man. Neuropharmacology 29 (1990a), 411-417.
29. Nicholson, A. N., P. A. Pascoe: Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology 30 (1991b), 367-372.
30. Nishihara, K., K. Mori, S. Endo, T. Ohta, K. Ohara: Relationship between sleep efficiency and urinary excretion of catecholamines in bed-rested humans. Sleep 8 (1985), 110-117.
31. Novak, M., C. M. Shapiro: Drug-induced sleep disturbances. Focus on nonpsychotropic medications. Drug. Saf. 16 (1997), 133-149.
32. Obermeyer, W. H., R. M. Benca: Effects of drugs on sleep. Neurol. Clin. 14 (1996), 827-840.
33. Paran, E., O. Anson, L. Neumann: The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients. Amer. J. Hypertens. 9 (1996), 1206-1213.
34. Paykel, E. S., R. Fleminger, J. P. Watson: Psychiatric side effects of antihypertensive drugs other than reserpine. J. Clin. Psychopharmacol. 2 (1982), 14-39.
35. Poole, M. D., D. S. Postma: Characterization of cough associated with angiotensin-converting enzyme inhibitors. Otolaryngol. Head. Neck Surg. 105 (1991), 714-716.
36. Prichard, B. N., C. W. Owens, B. R. Graham: Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. J. Hum. Hypertens. 11 Suppl. 1 (1997), S29-S45.
37. Prince, J. B., T. E. Wilens, J. Biederman, T. J. Spencer, J. R. Wozniak: Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J. Amer. Acad. Child Adolesc. Psychiatr. 35 (1996), 599-605.
38. Renton, K. W.: Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochem. Pharmacol. 34 (1985), 2549-2553.
39. Scharf, M. B., D. W. Mayleben: Comparative effects of prazosin and hydrochlorothiazide on sexual function in hypertensive men. Amer. J. Med. 86 (1989), 110-112.
40. Shimohira, M.,J. Kohyama, Y. Kawano, H. Suzuki, M. Ogiso, Y. Iwakawa: Effect of alpha-methyldopa administration during pregnancy on the development of a child's sleep. Brain Dev. 8 (1986), 416-423.
41. Sjoholm, T. T., T. Lehtinen, S. J. Piha: The effect of propranolol on sleep bruxism: hypothetical considerations based on a case study. Clin. Auton. Res. 6 (1996), 37-40.
42. Starke, K., D. Palm: Pharmakotherapie noradrenerger und adrenerger Systeme. Pharmakotherapie von Asthma bronchiale und primären Kopfschmerzen. In Forth, W., R. K. Henschler (eds.): All-gemeine und spezielle Pharmakologie und Toxikologie (Spektrum Akademischer Verlag: Heidelberg, 1996), 151-192.
43. Van-Den-Heuvel, C. J., K. J. Reid, D. Dawson: Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol. Behav. 61 (1997), 795-802.
44. VandenBurg, M. J., W. D. Cooper, M. L. Woollard, W. J. Currie, C. H. Bowker: Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa - a comparison with propranolol. Europ. J. Clin. Pharmacol. 26 (1984), 325-329.
45. Vgontzas, A. N., E. O. Bixler, D. A. Papanicolaou, A. Kales, C. A. Stratakis, B. A. Vela, P. W. Gold, G. P. Chrousos: Rapid eye movement sleep correlates with the overall activities of the hypothalamic-pituitary-adrenal axis and sympathetic system in healthy humans. J. Clin. Endocrinol. Metabol. 82 (1997), 3278-3280.
46. Wagner, M. L., A. S. Walters, R. G. Coleman, W. A. Hening, K. Grasing, S. Chokroverty: Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep. 19 (1996), 52-58.
47. Walker, B. R., L. E. Hare, M. W. Deitch: Comparative antihypertensive effects of guanabenz and clonidine. J. Int. Med. Res. 10 (1982), 6-14.
48. Weichler, U., B. Herres Mayer, J. Mayer, K. Weber, R. Hoffmann, J. H. Peter: Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 78 (1991), 124-130.